检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy

Antoni Ribas,Mohammed Milhem,Diwakar Davar,Patricia LoRusso,Zeynep Eroglu,Martin Gutierrez,Arindam Dhar,Carlos Becerra,Brian Di Pace, Tianli Wang, Hailei Zhang,Srimoyee Ghosh, Shyam Srivats,Theo Borgovan, Angela Waszak

Journal for ImmunoTherapy of Cancer（2023）

引用 0|浏览8
暂无评分
关键词
lung cancer,dostarlimab,cobolimab,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要